CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.106
-0.006 (-4.92%)
Dec 3, 2024, 12:27 PM EST - Market open
CNS Pharmaceuticals Employees
As of December 31, 2023, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,411,337
Market Cap
6.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5 | 0 | - |
Dec 31, 2022 | 5 | 0 | - |
Dec 31, 2021 | 5 | 0 | - |
Dec 31, 2020 | 5 | 0 | - |
Dec 31, 2019 | 5 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Biomerica | 64 |
Ainos | 46 |
Purple Biotech | 20 |
ABVC BioPharma | 19 |
NLS Pharmaceutics AG | 7 |
Adial Pharmaceuticals | 7 |
Xenetic Biosciences | 4 |
CNSP News
- 8 days ago - CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy - Accesswire
- 15 days ago - CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) - Accesswire
- 18 days ago - CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results - Accesswire
- 4 weeks ago - CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment - Accesswire
- 4 weeks ago - CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Accesswire
- 5 weeks ago - CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Accesswire
- 7 weeks ago - CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment - Accesswire
- 2 months ago - CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC - Accesswire